Fetus and newborn affected by other complications of labour and delivery

P16_FET_NEWB_OTH_COMPLICATIO_LABOUR_DELIV

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — P03 Cause of death: ICD-10 — P03 2 out of 7 registries used, show all original rules.	83
4. Check minimum number of events None	83
5. Include endpoints None	83
6. Filter based on genotype QC (FinnGen only)	83

Control definitions (FinnGen only)

Control exclude: P16_FET_NEWB_MATERN_FACTO_COMPLICATIO_PREGNAC_LABOUR_DELIV

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: P0[0-4]
Name in latin: Fetus et neonatus aliis complicationibus laborum et partus affectus

NAME	P16_FET_NEWB_OTH_COMPLICATIO_LABOUR_DELIV
CONTROL_EXCLUDE	P16_FET_NEWB_MATERN_FACTO_COMPLICATIO_PREGNAC_LABOUR_DELIV
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	P03
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	P03
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Fetus and newborn affected by other complications of labour and delivery based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	12078	5291	6784
Only index persons	3261	1433	1828
Unadjusted period prevalence (%)
Whole population	0.17	0.15	0.19
Only index persons	0.06	0.05	0.07
Median age at first event (years)
Whole population	0.01	0.00	0.00
Only index persons	0.00	0.00	0.00

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	83	51	32
Unadjusted period prevalence (%)	0.02	0.02	0.01
Median age at first event (years)	0.00	0.00	0.00

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
76: Matched controls
761

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

P03.4

ICD-10 Finland

Fetus and newborn affected by caesarean delivery

+∞

45.4

Z87.6

ICD-10 Finland

Personal history of certain conditions arising in the perinatal period

24.7

16.4

P03.0

ICD-10 Finland

Fetus and newborn affected by breech delivery and extraction

+∞

12.9

P03.3

ICD-10 Finland

Fetus and newborn affected by delivery by vacuum extractor [ventouse]

+∞

12.9

P03.1

ICD-10 Finland

Fetus and newborn affected by other malpresentation, malposition and disproportion during labour and delivery

+∞

9.6

P07.3

ICD-10 Finland

Other preterm infants

13.2

9.3

P01.5

ICD-10 Finland

Fetus and newborn affected by multiple pregnancy

+∞

8.5

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(1616796) Gas panel - Central venous blood

7.06

2.91

6.8

3.3

—

(3021440) Promyelocytes/100 leukocytes in Blood

3.27

2.80

4.5

7.2

0.2

0.0

—

(3017181) Myelocytes/100 leukocytes in Blood

3.09

2.58

4.5

7.1

2.0

0.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

4.13

2.30

1.4

2.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

3.02

2.06

2.3

2.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

3.95

1.97

1.3

2.1

—

(3019225) pH of Specimen

3.22

1.84

19.1

4.2

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.85

1.46

1.5

1.2

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

3.25

1.45

7.2

16.7

49.8

58.4

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

138

1.80

1.44

2.4

3.0

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2.01

1.32

1.8

2.0

—

(3032080) INR in Blood by Coagulation assay

119

1.77

1.24

3.5

5.1

1.1

inr

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

0.00

1.17

0.0

3.3

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

2.59

1.16

2.2

1.1

—

(3044640) Blood type and Crossmatch panel - Blood

167

1.61

1.07

2.6

3.2

—

(40760892) CBC W Ordered Manual Differential panel - Blood

142

1.64

1.05

4.0

5.1

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

0.00

1.00

0.0

1.7

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

0.00

1.00

0.0

2.1

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

329

1.48

0.95

5.3

7.0

5.7

5.9

mmol/l

0.24

294

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

307

0.65

0.94

1.9

1.8

0.4

3.4

u/ml

—

(3013512) EKG study

1.75

0.86

2.4

2.3

—

(3007164) IgA [Mass/volume] in Serum or Plasma

292

0.66

0.86

1.9

1.7

1.6

g/l

0.00

150

(3035637) Corticotropin [Mass/volume] in Plasma

1.94

0.83

2.3

1.8

—

(3007853) Bacteria identified in Skin by Aerobe culture

100

1.61

0.79

1.6

1.7

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2.24

0.77

1.6

1.2

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1.71

0.76

6.9

7.1

4937.9

1307.7

ng/l

—

(1761868) Lipid panel - Serum or Plasma

118

1.55

0.76

2.3

1.6

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1.75

0.75

5.1

7.2

92.8

90.4

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

118

0.55

0.75

2.1

1.6

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1.86

0.74

1.4

2.4

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

302

1.40

0.74

4.5

3.1

35.1

35.7

mmol/mol

0.14

278

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.52

0.72

1.0

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1.83

0.67

11.4

2.6

1.3

1.2

mmol/l

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1.64

0.67

1.3

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

240

1.39

0.66

4.2

4.3

—

(3023410) Appearance of Cerebral spinal fluid

0.00

0.61

0.0

5.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

0.00

0.61

0.0

1.9

—

2.5

—

(21494815) CD4 cells/100 lymphocytes in Specimen

0.00

0.60

0.0

2.8

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

178

0.68

0.57

1.8

—

(40758558) Short blood count panel - Blood

242

0.72

0.56

3.2

8.3

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1.52

0.55

3.2

2.8

164.6

19.7

ng/l

—

(3009508) Creatinine [Moles/volume] in Urine

145

1.40

0.54

7.6

4.8

8.1

8.4

mmol/l

0.11

134

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

164

0.68

0.52

6.7

4.8

37.2

33.9

u/l

0.11

155

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

147

1.38

0.50

11.3

11.2

-0.7

1.1

mmol/l

0.57

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

115

0.66

0.50

1.6

1.8

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

653

0.74

0.49

12.6

10.9

18.0

23.7

mg/l

0.81

435

(3037467) Urinalysis macro (dipstick) panel - Urine

387

1.29

0.48

7.6

4.4

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

339

0.77

0.46

2.0

1.9

—

(3026008) Bacteria identified in Urine by Culture

161

1.32

0.41

3.3

2.5

—

(3023520) Reticulocytes [#/volume] in Blood

1.36

0.41

5.1

4.7

64.3

59.5

e9/l

—

(42529406) Shigella sp [Presence] in Stool by Culture

0.00

0.41

0.0

1.2

—

(3008295) Osmolality of Serum or Plasma

0.00

0.41

0.0

1.2

—

294.6

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

0.00

0.41

0.0

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

0.00

0.41

0.0

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

0.00

0.40

0.0

1.3

—

(3021589) Normoblasts [#/volume] in Blood

404

0.80

0.39

8.5

10.7

0.0

e9/l

0.00

308

(3026493) Urate [Moles/volume] in Serum or Plasma

1.32

0.38

22.7

5.1

279.4

299.9

umol/l

—

(3018095) Leukocytes [#/volume] in Urine

239

1.25

0.37

5.8

6.0

20.9

41.3

e6/l

0.58

168

(46235355) HIV 1 and 2 tests - Meaningful Use set

229

0.78

0.37

1.6

2.2

—

(3003694) ABO and Rh group [Type] in Blood

230

1.25

0.37

1.6

1.7

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1.46

0.36

1.0

1.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1.37

0.35

3.7

2.5

916.0

4264.8

u/l

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1.37

0.32

5.0

13.7

105.4

106.2

mmol/l

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

139

0.76

0.30

1.9

2.0

—

(3009542) Hematocrit [Volume Fraction] of Blood

659

0.81

0.29

8.4

13.9

39.0

39.1

0.05

585

(3021447) Carbon dioxide [Partial pressure] in Venous blood

137

0.77

0.27

9.9

11.2

6.0

5.8

kpa

0.47

132

(3011397) Hemoglobin [Presence] in Urine by Test strip

158

0.79

0.27

2.9

3.6

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1.24

0.26

1.6

1.2

14.4

19.3

nmol/l

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1.20

0.25

4.6

3.6

2.6

2.7

g/l

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

0.72

0.25

2.0

1.5

—

(3027945) Reticulocytes/100 erythrocytes in Blood

1.28

0.23

5.7

7.4

1.6

1.2

0.67

(3029937) Albumin [Presence] in Urine by Test strip

145

1.21

0.22

4.9

4.4

0.0

estimate

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

154

0.81

0.21

10.9

13.5

24.1

24.7

mmol/l

0.69

154

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

0.00

0.21

0.0

2.0

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

2.1

—

1.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

0.00

0.21

0.0

1.2

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

0.00

0.21

0.0

2.0

—

(3045142) Bone marrow Pathology biopsy report

0.00

0.21

0.0

2.3

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

0.21

0.0

1.1

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.2

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

9.3

—

10.7

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

0.00

0.21

0.0

1.6

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.00

0.21

0.0

1.1

—

(44813793)

0.00

0.21

0.0

1.0

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

0.21

0.0

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

0.00

0.21

0.0

1.5

—

(4198724)

0.00

0.20

0.0

2.3

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

0.20

0.0

1.4

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

2.6

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

0.00

0.20

0.0

1.4

—

43.6

—

(3028300) Cannabinoids [Presence] in Urine

1.25

0.20

1.3

2.1

—

(42870588) Differential panel, method unspecified - Blood

302

1.15

0.20

5.5

9.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1.16

0.19

1.8

—

(40761536) Microorganisms panel - Urine sediment

1.16

0.19

6.8

3.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

207

1.15

0.17

2.1

2.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

207

1.15

0.17

1.8

2.0

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

1.12

0.16

1.3

2.3

—

(36660697) Celiac disease serology panel - Serum

129

0.83

0.16

1.2

1.3

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

208

1.14

0.15

9.8

5.4

—

(3016879) Cocaine [Presence] in Urine

1.11

0.15

1.2

2.2

—

(3000991) Gas panel - Venous blood

128

0.84

0.15

10.5

10.4

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

108

0.81

0.14

2.1

1.8

1.5

1.2

mmol/l

—

101

(3009261) Glucose [Presence] in Urine by Test strip

269

1.12

0.13

4.3

4.2

0.0

estimate

—

(3044889) 12 lead EKG panel

238

0.89

0.12

2.4

2.1

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

251

1.11

0.11

5.4

3.9

73.9

68.4

nmol/l

0.56

229

(3018418) pH of Serum or Plasma

114

0.86

0.10

7.0

3.8

7.4

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1.09

0.10

2.8

1.5

2.4

mmol/l

—

(3028707) Methadone [Presence] in Urine by Screen method

1.09

0.10

1.4

2.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1.07

0.09

1.8

1.7

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

0.78

0.08

2.2

1.7

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

104

0.85

0.06

3.9

1.7

—

(3041096) Erythrocytes [Presence] in Urine by Automated

138

1.10

0.06

5.5

3.8

—

(3027008) Opiates [Presence] in Urine

1.12

0.05

1.2

2.1

—

(3000764) Benzodiazepines [Presence] in Urine

1.12

0.05

1.2

2.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

698

0.92

0.04

3.6

3.7

—

(3021601) Nitrite [Presence] in Urine by Test strip

269

0.95

0.03

5.8

0.0

estimate

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

188

0.94

0.03

5.3

3.9

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

221

1.05

0.02

2.3

2.6

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

291

1.04

0.02

3.4

4.7

35.4

25.3

u/l

0.90

280

(36304419) Bacteria [Presence] in Urine

183

1.05

0.01

5.4

4.7

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

114

1.06

0.00

2.3

2.6

55.8

62.5

u/l

0.18

101

(40768804) Tissue Pathology biopsy report

154

1.05

0.00

1.4

1.7

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

123

0.97

0.00

2.1

1.4

94.3

94.8

pmol/l

—

(3035350) Ketones [Presence] in Urine by Test strip

269

1.00

0.00

4.6

4.1

0.0

estimate

—

(3019832) Treponema pallidum Ab [Presence] in Serum

152

0.98

0.00

1.5

1.8

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

371

0.99

0.00

5.7

6.8

109.5

112.8

ml/min/173m2

0.28

238

(40761511) CBC panel - Blood by Automated count

647

1.01

0.00

11.6

8.6

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

139

1.01

0.00

12.5

9.2

24.0

23.9

mmol/l

0.04

139

(3022313) Gas panel - Capillary blood

138

1.01

0.00

13.1

10.4

—

(3023368) Bacteria identified in Blood by Culture

107

1.03

0.00

2.1

3.6

—

(3015736) pH of Urine

211

0.99

0.00

3.0

3.8

—

(4268621)

0.00

0.0

2.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

0.00

0.0

1.0

—

(21494434) Karyotype in Bone marrow

0.00

0.0

1.8

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(4027681)

0.00

0.0

1.0

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.0

1.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

0.00

0.0

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.4

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.00

0.0

1.0

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

0.00

0.0

1.1

—

166.3

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3004588) Protein electrophoresis panel - Serum or Plasma

0.00

0.0

1.0

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

0.00

0.0

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

0.00

0.0

1.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.98

0.00

1.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

0.00

0.0

1.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.00

0.0

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

0.00

0.0

1.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

0.00

0.0

2.2

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

1.0

—

7.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

1.0

—

0.0

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

1.0

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

1.0

—

0.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.6

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

0.00

0.0

1.0

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

0.00

0.0

1.0

—

97.3

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.1

—

(3011288) Drugs identified in Urine by Screen method

0.87

0.00

1.5

2.7

—

(3028433) Virus identified in Specimen by Culture

0.00

0.0

1.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

0.00

0.0

1.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.00

0.0

7.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.4

—

(3023420) DNA double strand Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.2

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

0.86

0.00

1.0

1.2

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

0.98

0.00

2.4

1.9

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.3

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

0.00

0.0

1.0

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

0.00

0.0

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

0.00

0.0

1.4

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

0.00

0.0

1.4

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

0.93

0.00

1.4

—

(3000494) Fungus identified in Specimen by Culture

0.90

0.00

1.0

2.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

0.00

0.0

2.3

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.2

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

0.00

0.0

7.2

—

333.2

—

(3043409) Potassium [Moles/volume] in Arterial blood

0.00

0.0

3.0

—

4.0

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

1.0

—

38.7

—

(3035320) C reactive protein [Mass/volume] in Body fluid

0.00

0.0

2.6

—

(3027944) Amphetamines [Presence] in Urine

1.00

0.00

1.2

2.1

—

(4094501)

0.00

0.0

1.0

—

(40768441) Liver Pathology biopsy report

0.00

0.0

2.6

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

0.0

1.1

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

0.00

0.0

3.0

—

22.8

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3040893) Potassium [Moles/volume] in Capillary blood

0.00

0.0

4.0

—

4.5

—

(3033882) Carnitine [Moles/volume] in Serum or Plasma

0.00

0.0

2.4

—

30.4

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

1.0

—

0.0

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.00

0.0

1.0

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.1

—

(1002224) Polysomnography panel

0.00

0.0

1.3

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

1.0

—

0.0

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

0.00

0.0

2.7

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

0.3

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.00

0.0

1.0

—

(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma

0.00

0.0

2.4

—

21.6

—

Mortality – FinRegistry

↥

Association

Association between endpoint P16_FET_NEWB_OTH_COMPLICATIO_LABOUR_DELIV and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have P16_FET_NEWB_OTH_COMPLICATIO_LABOUR_DELIV.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: P16_FET_NEWB_OTH_COMPLICATIO_LABOUR_DELIV – Fetus and newborn affected by other complications of labour and delivery

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Fetus and newborn affected by other complications of labour and delivery

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints